Florent Malard, Jaime Sanz, Clemence Mediavilla, Lucia Lopez-Corral, Alexander Schauwvlieghe, Marc Bernard, Michael Loschi, Sylvie François, Francesca Bonifazi, Daniela Heidenreich, Marion Bruelle, Behzad Kharabi Masouleh, Emilie Plantamura, Ernst Holler, Mohamad Mohty. "MaaT013 for ruxolitinib-refractory acute graft-versus-host disease with gastrointestinal involvement: Results from the ARES phase III trial." Blood, 2025. doi:10.1182/blood-2025-817